- Home
- CBU vs AGIO Comparison
CBU vs AGIO Comparison
Compare CBU & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBU
- AGIO
- Stock Information
- Founded
- CBU 1866
- AGIO 2007
- Country
- CBU United States
- AGIO United States
- Employees
- CBU N/A
- AGIO N/A
- Industry
- CBU Major Banks
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- CBU Finance
- AGIO Health Care
- Exchange
- CBU Nasdaq
- AGIO Nasdaq
- Market Cap
- CBU 2.9B
- AGIO 2.5B
- IPO Year
- CBU N/A
- AGIO 2013
- Fundamental
- Price
- CBU $55.12
- AGIO $24.46
- Analyst Decision
- CBU Hold
- AGIO Buy
- Analyst Count
- CBU 2
- AGIO 7
- Target Price
- CBU $68.00
- AGIO $37.33
- AVG Volume (30 Days)
- CBU 223.8K
- AGIO 1.8M
- Earning Date
- CBU 10-21-2025
- AGIO 10-30-2025
- Dividend Yield
- CBU 3.43%
- AGIO N/A
- EPS Growth
- CBU 24.03
- AGIO N/A
- EPS
- CBU 3.88
- AGIO N/A
- Revenue
- CBU $776,264,000.00
- AGIO $44,791,000.00
- Revenue This Year
- CBU $13.91
- AGIO $25.57
- Revenue Next Year
- CBU $9.55
- AGIO $153.24
- P/E Ratio
- CBU $14.14
- AGIO N/A
- Revenue Growth
- CBU 9.90
- AGIO 36.26
- 52 Week Low
- CBU $49.44
- AGIO $22.24
- 52 Week High
- CBU $73.39
- AGIO $62.45
- Technical
- Relative Strength Index (RSI)
- CBU 43.40
- AGIO 25.59
- Support Level
- CBU $53.46
- AGIO $22.24
- Resistance Level
- CBU $56.72
- AGIO $46.00
- Average True Range (ATR)
- CBU 1.46
- AGIO 2.20
- MACD
- CBU -0.17
- AGIO -1.86
- Stochastic Oscillator
- CBU 29.41
- AGIO 8.76
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.